HLA-B and cancer: For non-permutated sequences, seven out of the twelve supertype representatives (HLA-A*01∶01, HLA-A*02∶01, HLA-A*03∶01, HLA-A*24∶02, HLA-A*26∶01, HLA-B*15∶01 and HLA-B*58∶01) had a significant lower fraction of predicted epitopes in sequences assigned to cancer pathology.